• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Miltefosine-[d4]

General Information
Catalog: BLP-004764
Molecular Formula: C21H42D4NO4P
Molecular Weight: 411.59
Chemical Structure
Miltefosine-[d4]
Description Miltefosine-[d4] is the labelled analogue of Miltefosine. Miltefosine is a phospholipid drug with antineoplastic and antiprotozoal/antifungal properties, also acts as an Akt inhibitor.
Synonyms Miltefosine d4; 2-[[(Hexadecyloxy)hydroxyphosphinyl]oxy]-N,N,N-trimethylethanaminium-d4; Hexadecylphosphocholine-d4; Miltex-d4; n-Hexadecylphosphocholine-d4; Impavido-D4
IUPAC Name hexadecyl [1,1,2,2-tetradeuterio-2-(trimethylazaniumyl)ethyl] phosphate
Related CAS 58066-85-6 (unlabelled)
Canonical SMILES CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C
InChI InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3/i19D2,21D2
InChI Key PQLXHQMOHUQAKB-KQHQIZQISA-N
Purity >98%
Solubility Slightly soluble in Methanol
Appearance Off-white Solid
Storage Store at 2-8°C under inert atmosphere

Interested in our Service & Products?
Need detailed information?

USA
  • International: 1-631-504-6093
  • US & Canada (Toll free): 1-844-BOC(262)-0123
  • 45-16 Ramsey Road, Shirley, NY 11967, USA
  • Email: info@bocsci.com
  • Fax: 1-631-614-7828
UK
  • 44-20-3286-1088
  • 85 Great Portland Street, London, W1W 7LT
  • Email: info@bocsci.com
Copyright © 2025 BOC Sciences. All Rights Reserved.
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x